Oncogenic role and therapeutic targeting of ABL-class and JAK-STAT activating kinase alterations in Ph-like ALL.Kathryn G. Roberts, Charles Mullighan, Zhaohui Gu et al.|PubMed|2017Cited by 114
ALL-456 Genomic Alterations in IKZF1 and Risk of Relapse in Childhood B-Cell Precursor Acute Lymphoblastic LeukemiaRuth Wang’ondu, Charles Mullighan, Emily Ashcraft et al.|Clinical Lymphoma Myeloma & Leukemia|2024Cited by 0
Genomic Alterations in IKZF1 and Risk of Relapse in Childhood B-Cell Precursor Acute Lymphoblastic LeukemiaRuth Wang’ondu, Charles Mullighan, Emily Ashcraft et al.|Clinical Lymphoma Myeloma & Leukemia|2024Cited by 0